BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Company’s Deep TMS™ H7 Coil for its use in treating adults suffering from major depressive disorder and depression including those with comorbid anxiety symptoms commonly known as anxious depression.
Hesai Reaches Strategic Cooperation With KargoBot, Empowering The Mass Production Of Autonomous Trucks
Today, Hesai Technology reached strategic cooperation with autonomous truck company, KargoBot. They will jointly promote the application of automotive-grade, hybrid solid-state lidar AT128 for L4 autonomous trucks,
